Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
Tóm tắt
Từ khóa
Tài liệu tham khảo
RG Boot, 2004, Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention, Blood, 103, 33, 10.1182/blood-2003-05-1612
AS Chen-Plotkin, 2011, Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease, Ann Neurol, 69, 655, 10.1002/ana.22271
WT Hu, 2010, Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease, Acta Neuropathol, 120, 385, 10.1007/s00401-010-0723-9
SE O’Bryant, 2010, A serum protein-based algorithm for the detection of Alzheimer disease, Arch Neurol, 67, 1077, 10.1001/archneurol.2010.215
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, <etal>et al</etal>.. (2011) Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol.
WT Hu, 2012, Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease, Neurology, 79, 897, 10.1212/WNL.0b013e318266fa70
D Johnstone, 2012, Multivariate protein signatures of pre-clinical Alzheimer’s disease in the Alzheimer’s disease neuroimaging initiative (ADNI) plasma proteome dataset, PLoS One, 7, e34341, 10.1371/journal.pone.0034341
Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, <etal>et al</etal>.. (2012) Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease. Arch Neurol: 1–8.
N Garge, 2010, Identification of quantitative trait loci underlying proteome variation in human lymphoblastoid cells, Mol Cell Proteomics, 9, 1383, 10.1074/mcp.M900378-MCP200
Lourdusamy A, Newhouse S, Lunnon K, Proitsi P, Powell J, <etal>et al</etal>.. (2012) Identification of cis-regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet.
D Melzer, 2008, A genome-wide association study identifies protein quantitative trait loci (pQTLs), PLoS Genet, 4, e1000072, 10.1371/journal.pgen.1000072
DB Friedman, 2008, Optimizing the difference gel electrophoresis (DIGE) technology, Methods Mol Biol, 428, 93, 10.1007/978-1-59745-117-8_6
L Gold, 2010, Aptamer-based multiplexed proteomic technology for biomarker discovery, PLoS One, 5, e15004, 10.1371/journal.pone.0015004
CR Jack Jr, 2008, The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods, J Magn Reson Imaging, 27, 685, 10.1002/jmri.21049
WJ Jagust, 2010, The Alzheimer’s Disease Neuroimaging Initiative positron emission tomography core, Alzheimers Dement, 6, 221, 10.1016/j.jalz.2010.03.003
RC Petersen, 2010, Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization, Neurology, 74, 201, 10.1212/WNL.0b013e3181cb3e25
LM Shaw, 2009, Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects, Ann Neurol, 65, 403, 10.1002/ana.21610
AJ Saykin, 2010, Alzheimer’s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans, Alzheimers Dement, 6, 265, 10.1016/j.jalz.2010.03.013
AJ Saykin, 2006, Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI, Neurology, 67, 834, 10.1212/01.wnl.0000234032.77541.a2
Risacher SL, Wudunn D, Pepin SM, Magee TR, McDonald BC, <etal>et al</etal>.. (2012) Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints. Neurobiology of aging.
SG Potkin, 2009, Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer’s disease, PLoS One, 4, e6501, 10.1371/journal.pone.0006501
S Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, 81, 559, 10.1086/519795
L Shen, 2010, Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort, Neuroimage, 53, 1051, 10.1016/j.neuroimage.2010.01.042
C Chelala, 2009, SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms, Bioinformatics, 25, 655, 10.1093/bioinformatics/btn653
AZ Dayem Ullah, 2012, SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update), Nucleic acids research, 40, W65, 10.1093/nar/gks364
CW Huang, 2009, Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer’s disease, J Clin Neurosci, 16, 1283, 10.1016/j.jocn.2008.12.026
C Laske, 2009, Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia, Eur Arch Psychiatry Clin Neurosci, 259, 80, 10.1007/s00406-008-0838-3
JK Lei, 2010, [Change of serum ACTH and cortisol levels in Alzheimer disease and mild cognition impairment], Zhonghua Yi Xue Za Zhi, 90, 2894
JN Souza-Talarico, 2010, Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer’s disease subjects, J Alzheimers Dis, 19, 839, 10.3233/JAD-2010-1282
Manly BFJ (2007) Randomization, bootstrap and Monte Carly methods in biology; Edition T, editor: Chapman & Hall/CRC Press.
WH Kruskal, 1952, Use of ranks in one-criterion variance analysis, Journal of the American Statistical Association, 47, 583, 10.1080/01621459.1952.10483441
RJ Pruim, 2010, LocusZoom: regional visualization of genome-wide association scan results, Bioinformatics, 26, 2336, 10.1093/bioinformatics/btq419
SB Gabriel, 2002, The structure of haplotype blocks in the human genome, Science, 296, 2225, 10.1126/science.1069424
JC Barrett, 2005, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics, 21, 263, 10.1093/bioinformatics/bth457
OA Panagiotou, 2012, What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations, International journal of epidemiology, 41, 273, 10.1093/ije/dyr178
A Schroder, 2013, Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver, The pharmacogenomics journal, 13, 12, 10.1038/tpj.2011.44
N Leveziel, 2010, [Genetic factors associated with age-related macular degeneration], Medecine sciences : M/S, 26, 509
R Martinez-Barricarte, 2012, Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration, Investigative ophthalmology & visual science, 53, 1087, 10.1167/iovs.11-8709
Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, <etal>et al</etal>.. (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int.
N Leban, 2012, Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations, International journal of immunogenetics, 39, 110, 10.1111/j.1744-313X.2011.01071.x
I Moore, 2010, Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome, Blood, 115, 379, 10.1182/blood-2009-05-221549
J Zhao, 2011, Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility, PLoS Genet, 7, e1002079, 10.1371/journal.pgen.1002079
M Thambisetty, 2008, Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease, J Neurol, 255, 1712, 10.1007/s00415-008-0006-8
M Kodera, 2005, Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis, Arthritis Rheum, 52, 2889, 10.1002/art.21257
S Struyf, 2003, PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia, Am J Pathol, 163, 2065, 10.1016/S0002-9440(10)63564-X
BS Youn, 1998, Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity, Biochem Biophys Res Commun, 247, 217, 10.1006/bbrc.1998.8762
SE Jamieson, 2007, Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil, Genes Immun, 8, 84, 10.1038/sj.gene.6364357
K Desai, 1989, Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation, J Lipid Res, 30, 831, 10.1016/S0022-2275(20)38312-7
EH Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443
SP Mooijaart, 2006, ApoE plasma levels and risk of cardiovascular mortality in old age, PLoS Med, 3, e176, 10.1371/journal.pmed.0030176
P van Vliet, 2007, Plasma levels of apolipoprotein E and risk of stroke in old age, Ann N Y Acad Sci, 1100, 140, 10.1196/annals.1395.012
VB Gupta, 2011, Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging, Neurology, 76, 1091, 10.1212/WNL.0b013e318211c352
K Taddei, 1997, Increased plasma apolipoprotein E (apoE) levels in Alzheimer’s disease, Neurosci Lett, 223, 29, 10.1016/S0304-3940(97)13394-8
Y Cui, 2011, Genetic ablation of apolipoprotein A-IV accelerates Alzheimer’s disease pathogenesis in a mouse model, Am J Pathol, 178, 1298, 10.1016/j.ajpath.2010.11.057
MH Yang, 2012, Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer’s disease, J Proteomics, 75, 3617, 10.1016/j.jprot.2012.04.017
TL Edwards, 2009, An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3, Am J Med Genet B Neuropsychiatr Genet, 150B, 721, 10.1002/ajmg.b.30899
Ning M, Yang Y, Zhang Z, Chen Z, Zhao T, <etal>et al</etal>.. (2010) Amyloid-beta-Related Genes SORL1 and ACE are Genetically Associated With Risk for Late-onset Alzheimer Disease in the Chinese Population. Alzheimer Dis Assoc Disord.
TS Ahluwalia, 2009, ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy, DNA Cell Biol, 28, 141, 10.1089/dna.2008.0810
Domingues-Montanari S, Hernandez-Guillamon M, Fernandez-Cadenas I, Mendioroz M, Boada M, <etal>et al</etal>.. (2011) ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Neurobiol Aging 32: 551 e513–522.
WS Watkins, 2010, AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees, Am J Hypertens, 23, 917, 10.1038/ajh.2010.83
E Balam-Ortiz, 2011, Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population, Am J Med Sci, 342, 205, 10.1097/MAJ.0b013e3182121020
E Balam-Ortiz, 2012, Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension, Hypertension, 59, 847, 10.1161/HYPERTENSIONAHA.111.176453
C Rotimi, 1997, Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians, Circulation, 95, 2348, 10.1161/01.CIR.95.10.2348
E Fisher, 2009, Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study, Circ Cardiovasc Genet, 2, 607, 10.1161/CIRCGENETICS.109.870410
D Geroldi, 2005, Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer’s disease in Italians, Neurosci Lett, 386, 176, 10.1016/j.neulet.2005.06.014
DF Gudbjartsson, 2010, Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases, PLoS Genet, 6, e1001039, 10.1371/journal.pgen.1001039
A Kottgen, 2010, Uromodulin levels associate with a common UMOD variant and risk for incident CKD, J Am Soc Nephrol, 21, 337, 10.1681/ASN.2009070725
Han J, Chen Y, Liu Y, Liang Y, Wang X, <etal>et al</etal>.. (2012) Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort. Hypertens Res.
L Bartalena, 1990, Recent achievements in studies on thyroid hormone-binding proteins, Endocr Rev, 11, 47, 10.1210/edrv-11-1-47
OE Janssen, 1992, Molecular basis of inherited thyroxine-binding globulin defects, Trends Endocrinol Metab, 3, 49, 10.1016/1043-2760(92)90043-Z